Payers generally meet drug price watchdog's 'fair access' standards, report says
The Institute for Clinical and Economic Review said major insurers’ drug coverage policies generally do align with the pricing watchdog’s set of “fair access” standards …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
